FAS:ARCA-Direxion Financial Bull 3X Shares

ETF | Trading--Leveraged Equity | NYSE Arca

Last Closing

USD 49.24

Change

0.00 (0.00)%

Market Cap

USD 1.39B

Volume

1.48M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the Russell 1000? Financial Services Index. The fund creates long positions by investing at least 80% of its assets in the securities that comprise the Russell 1000? Financial Services Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index is a subset of the Russell 1000? Index that measures the performance of the securities classified in the financial services sector of the large-cap U.S. equity market. It is non-diversified.

Inception Date: 06/11/2008

Primary Benchmark: Russell 1000 Financial Services TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.97%

Management Expense Ratio: 1.04 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-01-12 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Mer Price(Change) Market Cap
SSO ProShares Ultra S&P500 0.90 %

N/A

USD 2.34B
QLD ProShares Ultra QQQ 0.95 %

N/A

USD 1.79B
UPRO ProShares UltraPro S&P 500 0.92 %

N/A

USD 1.30B
NUGT Direxion Daily Gold Miners Ind.. 0.94 %

N/A

USD 1.28B
SPXL Direxion Daily S&P 500 Bull 3X.. 1.00 %

N/A

USD 0.95B
JNUG Direxion Daily Junior Gold Min.. 0.93 %

N/A

USD 0.82B
UYG ProShares Ultra Financials 0.95 %

N/A

USD 0.80B
TNA Direxion Small Cap Bull 3X Sha.. 1.10 %

N/A

USD 0.70B
TECL Direxion Technology Bull 3X Sh.. 1.17 %

N/A

USD 0.69B
LABU Direxion Daily S&P Biotech Bul.. 1.14 %

N/A

USD 0.59B

ETFs Containing FAS

PMPT iSectors Post-MPT Growth .. 6.12 % 0.81 %

N/A

USD 5.46M

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.98% 49% F 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.98% 49% F 81% B-
Trailing 12 Months  
Capital Gain -33.91% 47% F 12% F
Dividend Return 0.86% 74% C 13% F
Total Return -33.06% 47% F 11% F
Trailing 5 Years  
Capital Gain 113.83% 84% B 95% A
Dividend Return 3.12% 61% D- 10% F
Total Return 116.95% 81% B- 94% A
Average Annual (5 Year Horizon)  
Capital Gain 33.49% 89% B+ 97% A+
Dividend Return 33.65% 90% A- 97% A+
Total Return 0.16% 25% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 40.95% 34% F 10% F
Risk Adjusted Return 82.17% 81% B- 76% C
Market Capitalization 1.39B 99% A+ 65% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.